Alpha-GPC — The Choline Donor
Alpha-GPC (alpha-glycerylphosphorylcholine) is the most bioavailable form of choline — a precursor to acetylcholine (the learning and memory neurotransmitter) and phosphatidylcholine (a key membrane phospholipid). It is used clinically in Europe for Alzheimer's disease and vascular dementia.
Mechanism of Action
Alpha-GPC is hydrolyzed to choline and glycerophosphate in the gut. Choline crosses the blood-brain barrier and is acetylated to acetylcholine by choline acetyltransferase. Acetylcholine is essential for memory consolidation, attention, and neuromuscular function. Alpha-GPC also increases growth hormone release and may support neuronal membrane repair.
Human Trial Evidence
A 2007 Journal of the Neurological Sciences trial showed Alpha-GPC improved cognitive function and motivation in healthy volunteers. Multiple European trials (Parnetti et al.) show Alpha-GPC improves cognitive scores in Alzheimer's and vascular dementia patients. A 2008 trial showed 600 mg Alpha-GPC significantly increased growth hormone response to exercise.
Dosing Protocol
300–600 mg/day. Cognitive enhancement: 300 mg 2–3× daily. Pre-workout (GH release): 600 mg 30–60 min before exercise. Take with food. Often combined with racetams (synergistic choline demand).
Safety & Contraindications
Well-tolerated. Mild GI effects at high doses. May worsen symptoms in cholinergic conditions (e.g., Parkinson's disease on cholinesterase inhibitors). Theoretical concern: choline is converted to TMAO by gut bacteria — TMAO is associated with cardiovascular risk, though this has not been shown for Alpha-GPC specifically.